Sandbox

Microbial Screening Technologies

  • Establishment

    Microbial Screening Technologies established

    Continue reading

  • Industry Partnership

    Discovery of microbial natural products as next gen anthelmintics, in partnership with Novartis Animal Health

  • Patent

    Larval development assay – detection of anthelmintic resistance in parasitic nematodes infecting grazing animals

  • Industry Partnership

    Discovery of GUS gene activators to protect against pathogenic fungi in crops, in partnership with Syngenta

  • Patent

    Novel terpenylated diketopiperazines (drimentines) for the treatment of bacterial, fungal, endoparasite and ectoparasite infections, cancer and other malignant diseases in human and animal health, in collaboration with Novartis Animal Health

  • GRANT

    Australian Research Council SPIRT grant to explore biopesticides for veterinary health

  • Industry Partnership

    Discovery of marine microbial metabolites for crop protection

  • GRANT

    Australian Research Council SPIRT grant to explore new antibiotics from Australian microbes

  • Grant

    Biotech Innovation Fund grant to investigate nuclear export of proteins as a target in chemotherapy

  • 15 Publications

  • Patent

    Protection and immunization of plants against attack by phytopathogenic microorganisms, in partnership with Novartis

  • Patent

    New use of albofungin and analogues as anthelmintics, in partnership with Novartis Animal Health

  • Industry Partnership

    Isolation and structural elucidation of tigilanol tiglate, later commercialized for topical use as an anticancer agent in domestic animals by Ecobiotics

  • Patent

    Novel biocide compound, isonemadectin, and analogues and uses thereof

  • Commercial venture

    Commercialization of the larval development and larval motility assays for infield assessment of drug resistance in parasite populations

  • Industry Partnership

    Identification of contaminant in commercial dog food causing significant toxicity

  • Industry Partnership

    Discovery of unique, biologically active compounds in milk, in partnership with IMB and Murray Goulburn Cooperative Co Ltd.

  • 19 Publications

  • Patent

    Polyketide xanthones of the kibdelone class and their use as antibacterial and anticancer agents, in collaboration with IMB

  • Industry Partnership

    Antibiotic discovery project

  • Commercial venture

    Launch of BioAustralis Fine Chemicals, selling known metabolites isolated during MST’s discovery program for in vitro laboratory use

  • Grant

    Australian Research Council Linkage grant with IMB for discovery of next generation anthelmintics

  • Strategic Partnership

    Provision of a comprehensive metabolite standards library to Biotica Ltd support novel drug discovery

  • Industry Partnership

    Characterisation of metabolites of Duddingtonia flagrans for use as a commercial animal health product

  • 12 Publications

  • Grant

    Australian Research Council Linkage grant with IMB for drug discovery, growing a sustainable new molecular resource

  • Strategic Partnership

    Provision of the full range of BioAustralis fine chemicals to a major U.S. life sciences company

  • Strategic Partnership

    Provision of a library containing known metabolites to support the biocontrol discovery program of a major European multinational

  • 21 Publications

  • Acquisition

    Acquisition of the Amrad/Cerylid library of 25,000 milled and dried Australian plants

    Continue reading

  • Grant

    AusIndustry CRC-P grant to deliver Probio-TICK, a sustainable microbial probiotic against cattle tick and buffalo fly for northern Australia, in collaboration with Meat and Livestock Australia and Macquarie University.

  • Grant

    AusIndustry CRC-P grant to expand the BioAustralis range to 5,000 microbial metabolites and related compounds, in collaboration with University of Western Australia, Macquarie University and Advanced Veterinary Therapeutics

  • Strategic Partnership

    Preparation of custom library of known and novel microbial metabolites to investigate plant antifungal potential

  • Acquisition

    Acquisition of the former Merck natural product plant library.

    Continue reading

  • Patent

    Probiotic compositions – composition of bacterial organisms active against ectoparasites, emanating from the Probio-TICK CRC-P

  • 25 publications

  • Patent

    6 Australian innovation patents from the research conducted into antivirals, nematocides and anti-protozoans

  • Strategic Partnership

    Preparation of a custom library of known and novel microbial metabolites with plant antifungal activity to support biocontrol discovery and development

  • Industry Partnership

    Microbial biodiversity across the Australian continent

  • Industry Partnership

    Discovery of biostimulant microorganisms for agricultural use

  • Grant

    ARC linkage grant with University of Western Australia for advanced biomanufacturing to enhance the production of cryptic metabolites

  • Commercial agreement

    Licensing of a microbial strain for use as a biostimulant in agriculture.

    Continue reading

  • 33 publications